Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119535) titled 'A multicenter, randomized, double-blind controlled study on the treatment of refractory depression by accelerating intermittent theta burst stimulation (a-iTBS) targeting the left primary motor cortex (M1)' on Feb. 28.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Affiliated Kangning Hospital of Ningbo University
Condition:
Depressive
Intervention:
The sham aiTBS group:Sham stimulation group
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-07
Target Sample Size: The sham aiTBS group:80;The active aiTBS group:80;
Countries of Recruitment...